Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 168.0 | 133.6 | 64.4 | 43.7 |
| Revenue growth | 25.8% | 107.3% | 47.6% | |
| Cost of goods sold | 64.0 | 47.2 | 20.4 | 12.6 |
| Gross profit | 104.0 | 86.4 | 44.0 | 31.0 |
| Gross margin | 61.9% | 64.7% | 68.3% | 71.1% |
| Sales and marketing | 46.3 | 25.7 | 19.4 | 12.0 |
| Research and development | 110.7 | 49.5 | 23.6 | 14.4 |
| General and administrative | 30.3 | 18.0 | 7.2 | 5.4 |
| EBITA | -78.4 | -5.2 | -6.1 | 0.3 |
| EBITA margin | -46.7% | -3.9% | -9.5% | 0.6% |
| Amortization of intangibles | 1.9 | | | |
| EBIT | -80.4 | -5.2 | -6.1 | 0.3 |
| EBIT margin | -47.8% | -3.9% | -9.5% | 0.6% |
| Pre-tax income | -71.8 | -2.6 | -5.4 | 0.5 |
| Income taxes | -0.8 | 0.6 | 0.8 | 0.1 |
| Tax rate | 1.2% | | | 21.8% |
| Net income | -72.4 | -203.3 | -66.9 | -42.8 |
| Net margin | -43.1% | -152.2% | -103.8% | -98.1% |
| |
| Diluted EPS | ($0.16) | ($0.76) | ($0.58) | ($0.39) |
| Shares outstanding (diluted) | 440.9 | 268.8 | 115.7 | 109.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|